Profit from pest control with Rentokil Initial
Rentokil Initial is set for global expansion and offers strong sales growth
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Twice daily
MoneyWeek
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Four times a week
Look After My Bills
Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!
One of the recurring themes of this column is that some of the best opportunities are provided by firms in industries that aren’t glamorous but are important. One industry that certainly fits the bill is pest control. If you run a restaurant, you’ll know how vital pest control is to your survival, as no one wants to eat in a place with flies in their soup – or worse. Similarly, as emerging markets become richer and people move into cities, their tolerance for pests dwindles. Rentokil Initial (LSE: RTO) is one company perfectly positioned to take advantage.
Founded in the UK just over 100 years ago, Rentokil dominates the UK market and has expanded overseas by acquiring companies in other countries and integrating them into the Rentokil brand. The most notable of these purchases was US company Terminix in 2022, which made Rentokil the largest company in the US, the biggest market in the world. Rentokil is now the world’s biggest pest-control company, operating in 90 countries, including virtually all of the world’s largest cities.
Rentokil Initial has ambitious plans for growth
The global pest-control market is expected to grow by 5%-6% a year over the next few years, and Rentokil has ambitious plans for giving its growth a further fillip. Firstly, it wants to expand into the countries where it doesn’t have a presence. It is also investing in digital technology to make its operations more effective and to keep costs down.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The group also plans to expand its hygiene and washrooms business, which currently accounts for 20% of its revenue. At the same time, the sale of its workwear business to HIG Capital in October 2025 will not only make it a tidy sum of money but will also help keep the company streamlined and focused. Rentokil has seen its revenue double between 2019 and 2024, while its earnings per share have gone up by nearly two-thirds during the same period (and are expected to keep growing rapidly over the next few years). The company makes a solid 7% return on capital employed, a key gauge of profitability, and boasts a double-digit operating margin, which has helped it increase its dividend sixfold from 2019, while still investing in the business and keeping debt at manageable levels. All this more than justifies the fact that it trades at 19.4 times 2026 earnings; the stock also offers a dividend yield of 2.2%. In addition to strong fundamentals,
Rentokil’s stock has plenty of momentum. Over the second half of 2025, Rentokil was one of the stars of the FTSE 100, rising 38%. As a result, the shares trade well above their 50 and 200-day moving averages. With several brokers, including Morgan Stanley, recently upgrading Rentokil, I suggest that you buy it at the current price of 471p at £6 per 1p. In that case, I would put the stop-loss at 316p, which would give you a total downside of £930.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

-
RICS: UK housing market showing signs of 'tentative recovery'RICS members are becoming less negative about property sales and house prices. What does the latest data mean for the property market?
-
Last chance to invest in VCTs? Here's what you need to knowInvestors have pumped millions more into Venture Capital Trusts (VCTS) so far this tax year, but time is running out to take advantage of tax perks from them.
-
Three key winners from the AI boom and beyondJames Harries of the Trojan Global Income Fund picks three promising stocks that transcend the hype of the AI boom
-
RTX Corporation is a strong player in a growth marketRTX Corporation’s order backlog means investors can look forward to years of rising profits
-
Profit from MSCI – the backbone of financeAs an index provider, MSCI is a key part of the global financial system. Its shares look cheap
-
'AI is the real deal – it will change our world in more ways than we can imagine'Interview Rob Arnott of Research Affiliates talks to Andrew Van Sickle about the AI bubble, the impact of tariffs on inflation and the outlook for gold and China
-
Should investors join the rush for venture-capital trusts?Opinion Investors hoping to buy into venture-capital trusts before the end of the tax year may need to move quickly, says David Prosser
-
Food and drinks giants seek an image makeover – here's what they're doingThe global food and drink industry is having to change pace to retain its famous appeal for defensive investors. Who will be the winners?
-
Barings Emerging Europe trust bounces back from Russia woesBarings Emerging Europe trust has added the Middle East and Africa to its mandate, delivering a strong recovery, says Max King
-
How a dovish Federal Reserve could affect youTrump’s pick for the US Federal Reserve is not so much of a yes-man as his rival, but interest rates will still come down quickly, says Cris Sholto Heaton